(Q41073200)

English

Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

scientific article published on January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 September 2017

1 reference

Europe PubMed Central

Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? (English)

1 reference

Europe PubMed Central

26 September 2017

0 references

author name string

B M Devereaux

1

1 reference

Europe PubMed Central

26 September 2017

D H Crawford

2

1 reference

Europe PubMed Central

26 September 2017

P Purcell

3

1 reference

Europe PubMed Central

26 September 2017

L W Powell

4

1 reference

Europe PubMed Central

26 September 2017

H P Roeser

5

1 reference

Europe PubMed Central

26 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1995

1 reference

Europe PubMed Central

26 September 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

26 September 2017

49

1 reference

Europe PubMed Central

26 September 2017

81-85

1 reference

Europe PubMed Central

26 September 2017

1-2

1 reference

Europe PubMed Central

26 September 2017

Erythromycin-associated cholestatic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin-induced cholestatic liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pitfall in diagnosis of viral hepatitis on haemodialysis unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis from intravenous high-dose oxacillin therapy: findings in an adult inpatient population

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for development of flucloxacillin associated jaundice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic hepatitis associated with flucloxacillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic jaundice due to derivatives of oxacillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced cholestatic hepatitis from common antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin-associated liver damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver damage from flucloxacillin, cloxacillin and dicloxacillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin jaundice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin induced delayed cholestatic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flucloxacillin and cholestatic hepatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged hepatic cholestasis after flucloxacillin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged severe cholestasis induced by oxacillin derivatives. A report on two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CHOLESTATIC HEPATITIS FOLLOWING THE ADMINISTRATION OF SODIUM OXACILLIN

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/8751026

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41073200&oldid=1645710737"